Delivery Order SPE2DB22D3501-SPE2DB25FWM76
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,431.30 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). This contract, awarded on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $45,611.82 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed price delivery order was issued without set-aside provisions and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a standard pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Eliquis 5 mg tablets (60-count units) valued at $14,873.42 under a firm fixed-price contract. This non-set-aside delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements, with performance to be completed by July 21, 2025, and fulfillment from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,056.52 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on July 21, 2025, with completion targeted for July 22, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is being performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $7,924.38 on July 18, 2025, for the supply of Eliquis 5 mg tablets (60-count). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and calls for ultimate completion by July 21, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $10,308.12 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This is a firm fixed price, non-set-aside contract with a completion date of July 22, 2025, and performance location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a relatively small transaction within the company's extensive federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) valued at $3,484.49. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December 2026. The delivery order carries an ultimate completion date of July...
- The Defense Logistics Agency awarded a delivery order valued at $83,800.36 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This competitive award, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and serves the federal medical supply chain...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $13,452.67. This firm fixed-price delivery order is scheduled for completion by July 21, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order issued without set-aside restrictions, drawing from AmerisourceBergen's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $49,278.05 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract. The award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWM76Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,546.60 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems, and demonstrates significant capability to fulfill competitive federal medical supply requirements across multiple therapeutic domains and delivery modalities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 7/21/25 |